Categories: News

Cannabix Technologies announces Stock Option Grant and Director Resignation

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

VANCOUVER, British Columbia, March 14, 2025 (GLOBE NEWSWIRE) — Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) reports it is granting 3,375,000 incentive stock options to officers, directors and consultants of the Company, exercisable at $0.54 per share for five years, of which 650,000 will expire in two years and will be subject to vesting provisions.

In addition, the Company reports that Thomas Clarke has resigned as a Director of the Company. The Company thanks Mr. Clarke for his contributions and wishes him well in his future endeavours.

The Company has engaged InvestorsHub.com Inc. (“InvestorsHub”) for news release dissemination services for a fee of $20,000 USD effective May 14, 2025 until the budget is exhausted. The Company may elect to renew the engagement in the future. Consideration paid to InvestorsHub does not include any securities of the Company (address: PO Box 780, Harrisonville, MO 6470, 888-498-5839).

We seek Safe Harbor.

On behalf of the Board of Directors

“Rav Mlait”

CEO
Cannabix Technologies Inc.

For further information, contact the Company at info@cannabixtechnologies.com

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Staff

Recent Posts

Harbinger Health Showcases Multi-Cancer Early Detection Performance in High-Risk Populations at ASCO 2025

Reflex blood-based multi-cancer early detection (MCED) test demonstrated clinically meaningful per-cancer Positive Predictive Value (PPV)…

12 hours ago

ImPact Biotech Presents Interim Analysis from Phase 3 ENLIGHTED Study of Padeliporfin VTP in LG UTUC at ASCO 2025

– Complete response (CR) observed in 73% (27/37) of evaluable patients with low-grade upper tract urothelial…

12 hours ago